Using real-world data, researchers compared the clinical findings of multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activating syndrome due to systemic juvenile idiopathic arthritis.
In a systematic review and meta-analysis, study authors evaluated the effectiveness of monoclonal antibodies and anticytokine biologics in the treatment of Kawasaki disease.
Researchers assessed whether the COVID-19 pandemic was associated with the occurrence of Kawasaki disease or multi-inflammatory syndrome in children.
Study researchers sought to assess the link between Kawasaki disease and patient cognitive profiles or caregiver parenting stress.
Authors described the reduction in Kawasaki disease incidence in Korea after the implementation of nonpharmaceutical interventions during the COVID-19 pandemic.
The incidence of Kawasaki disease (KD) in South Korea decreased sharply after implementation of nonpharmaceutical interventions (NPIs), such as mask wearing and hand washing, were introduced to mitigate the spread of COVID-19.
Researchers conducted a meta-analysis to evaluate the association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease.
The C-reactive protein to albumin ratio is a novel inflammation marker that may be a valuable predictor of coronary artery lesion formation in Kawasaki disease.
Clinical outcomes of and treatment for Kawasaki disease were found to be distinct for Black and White children.
Adding corticosteroids to initial IV immunoglobulin may reduce risk for coronary artery abnormalities.
